Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04854434
Title A Study to Evaluate the Safety and Efficacy of Selinexor With or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With RAS Mutations
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Karyopharm Therapeutics Inc
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST